Article

Extended Multigene Panel Testing in a High-Risk Brazilian Public Health Cohort: Pathogenic Variant Prevalence and the Role of Self-Reported Ethnicity

2026-05-04

Abstract excerpt

<title>Abstract</title> <p> Background: Breast cancer remains the most common malignancy among women in Brazil, with a substantial proportion attributable to hereditary predisposition. Data regarding germline pathogenic variants in ethnically diverse, self-reported populations within public health settings remain limited. <h4>Objective:</h4> To evaluate the prevalence of pathogenic/likely pathogenic variants (P...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ca2edea3-d8cd-5562-8a44-4cdabc8f2e91
DOI: 10.21203/rs.3.rs-9371542/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Extended Multigene Panel Testing in a High-Risk Brazilian Public Health Cohort: Pathogenic Variant Prevalence and the Role of Self-Reported EthnicityDOI 10.21203/rs.3.rs-9371542/v1Read

Spectrum of germline pathogenic variants in Brazilian hereditary breast/ovarian cancer cases.Semantic proximity Read

Whole genome profiling of 400 patients at risk for hereditary cancer in a Brazilian cohortSemantic proximity Read

The genetics of hereditary cancer risk syndromes in Brazil: a comprehensive analysis of 1682 patientsSemantic proximity Read

Prevalence of Pathogenic Germline Variants in Cancer Susceptibility Genes using the All of Us DatasetSemantic proximity Read

Hereditary cancer testing in a diverse sample across three breast imaging centers.Semantic proximity Read

Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations: A Secondary Analysis of the WISDOM Study.Semantic proximity Read

Germline Pathogenic Variant Prevalence Among Latin American and US Hispanic Individuals Undergoing Testing for Hereditary Breast and Ovarian Cancer: A Cross-Sectional StudySemantic proximity Read

Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working GroupSemantic proximity Read

Universal Genetic Testing for Newly Diagnosed Invasive Breast Cancer.Semantic proximity Read

Prevalence of BRCA1 and BRCA2 Variants in an Unselected Population of Women With Breast Cancer.Semantic proximity Read

Cancer patterns and recurrent variants in BRCA1 and BRCA2 carriers from a Brazilian oncogenetics cohortSemantic proximity Read

Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.Semantic proximity Read